NCT07932054
Immune Reconstitution Characteristics and Influencing Factors Following Umbilical Cord Blood Transplantation
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
The quantity and diversity of immune cells
Timeframe: On post-transplant days 30 ± 3, 60 ± 3, 90 ± 3, 120 ± 3, 180 ± 7, 270 ± 7, and 360 ± 7
Secondary (6)
Incidence of engraftment syndrome
Incidence of infections
Incidence of relapse
Incidence of non-relapse mortality
Incidence of graft-versus-host disease
Show 1 moreShow less
survival
Sites
1 site in 1 country
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeTianjin, China